Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common stock, $0.0001 par value
-
Shares outstanding
-
78.4M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
8.36M
-
Shares change
-
+8.13M
-
Total reported value, excl. options
-
$17M
-
Value change
-
+$16.3M
-
Number of buys
-
13
-
Number of sells
-
-3
-
Price
-
$2.03
Significant Holders of CITIUS ONCOLOGY, INC. - Common stock, $0.0001 par value (CTOR) as of Q3 2025
17 filings reported holding CTOR - CITIUS ONCOLOGY, INC. - Common stock, $0.0001 par value as of Q3 2025.
CITIUS ONCOLOGY, INC. - Common stock, $0.0001 par value (CTOR) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.36M shares
of 78.4M outstanding shares and own 10.66% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (7.68M shares), VANGUARD GROUP INC (180K shares), GEODE CAPITAL MANAGEMENT, LLC (167K shares), XTX Topco Ltd (127K shares), RENAISSANCE TECHNOLOGIES LLC (55.9K shares), STATE STREET CORP (42.9K shares), IFP Advisors, Inc (33.2K shares), NORTHERN TRUST CORP (21.8K shares), CITADEL ADVISORS LLC (17.7K shares), and Tower Research Capital LLC (TRC) (11.8K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.